Bioactivity:

1. Corynoxeine is a potent ERK1/2 inhibitor of key PDGF-BB-induced VSMC proliferation and may be useful in the prevention and treatment of vascular diseases and restenosis after angioplasty.

CAS nr:

630-94-4

Purity:

98%

Molecular Weight:

382,46

SMILES:

CO\C=C(/[C@H]1C[C@@H]2N(CC[C@]22C(=O)Nc3ccccc23)C[C@@H]1C=C)C(=O)OC

Formula:

C22H26N2O4

Pathway:

MAPK

Target:

ERK